Skip to main content
SkinCited

Nicotinamide: An Update and Review of Safety & Differences from Niacin.

Reed Huber, Aaron Wong
Other Skin therapy letter 2020 13 citazioni
PubMed
<\/script>\n
`; }, get iframeSnippet() { const domain = 'skincited.com'; const params = 'pmid\u003D33196157'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Tipo di studio
Other
Popolazione
None
Intervento
Nicotinamide: An Update and Review of Safety & Differences from Niacin. None
Comparatore
None
Esito primario
None
Direzione dell'effetto
Mixed
Rischio di bias
Unclear

Abstract

Nicotinamide (or niacinamide), a form of vitamin B3 that is often confused with its precursor nicotinic acid (or niacin), is a low-cost, evidence-based oral treatment option for actinic keratosis, squamous cell carcinomas, basal cell carcinomas, and bullous pemphigoid. Despite its favorable safety profile and affordability, the integration of nicotinamide into clinical practice is an ongoing process, and like many over-the-counter supplements it has faced some barriers. The purpose of this article is to address some of those barriers by reviewing its efficacy, safety profile, and emphasizing the difference between nicotinamide and niacin. Lastly, we offer practical guidance around recommendations and the availability of nicotinamide, which can be hard to find for patients and providers alike.

TL;DR

The purpose of this article is to address some of barriers to the integration of nicotinamide into clinical practice by reviewing its efficacy, safety profile, and emphasizing the difference between Nicotinamide and niacin.

Used In Evidence Reviews

Similar Papers